Toronto Dominion Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.2M Sell
909,773
-430,738
-32% -$25.1M 0.08% 222
2025
Q4
$72.3M Buy
1,340,511
+110,058
+9% +$5.29M 0.11% 181
2025
Q3
$55.5M Buy
1,230,453
+67,817
+6% +$3.17M 0.09% 216
2025
Q2
$53.8M Buy
1,162,636
+445,071
+62% +$21.8M 0.09% 193
2025
Q1
$43.8M Sell
717,565
-384,325
-35% -$22.4M 0.09% 185
2024
Q4
$62.3M Buy
1,101,890
+266,806
+32% +$14.9M 0.1% 150
2024
Q3
$43.2M Sell
835,084
-250,023
-23% -$11.7M 0.08% 179
2024
Q2
$45.1M Sell
1,085,107
-171,332
-14% -$7.67M 0.07% 165
2024
Q1
$68.1M Buy
1,256,439
+16,941
+1% +$863K 0.11% 130
2023
Q4
$63.6M Buy
1,239,498
+270,416
+28% +$14.2M 0.09% 162
2023
Q3
$56.2M Sell
969,082
-389,256
-29% -$23.9M 0.09% 170
2023
Q2
$86.8M Buy
1,358,338
+77,843
+6% +$5.22M 0.13% 131
2023
Q1
$88.7M Buy
1,280,495
+18,803
+1% +$1.33M 0.14% 121
2022
Q4
$90.7M Buy
1,261,692
+172,210
+16% +$13M 0.14% 122
2022
Q3
$77.4M Sell
1,089,482
-88,068
-7% -$6.39M 0.14% 112
2022
Q2
$90.7M Sell
1,177,550
-306,399
-21% -$23.3M 0.17% 93
2022
Q1
$108M Sell
1,483,949
-564,294
-28% -$37.9M 0.16% 97
2021
Q4
$128M Buy
2,048,243
+303,891
+17% +$17.8M 0.17% 93
2021
Q3
$103M Buy
1,744,352
+652,451
+60% +$43M 0.16% 92
2021
Q2
$73M Sell
1,091,901
-115,386
-10% -$7.52M 0.11% 121
2021
Q1
$76.2M Sell
1,207,287
-686,558
-36% -$42.7M 0.13% 108
2020
Q4
$117M Buy
1,893,845
+506,024
+36% +$31.1M 0.22% 76
2020
Q3
$83.7M Sell
1,387,821
-192,583
-12% -$11.6M 0.21% 82
2020
Q2
$92.9M Sell
1,580,404
-539,860
-25% -$32.3M 0.24% 79
2020
Q1
$118M Sell
2,120,264
-161,726
-7% -$9.88M 0.36% 48
2019
Q4
$146M Buy
2,281,990
+1,004,591
+79% +$57.5M 0.25% 72
2019
Q3
$64.8M Sell
1,277,399
-1,162,351
-48% -$54.6M 0.14% 120
2019
Q2
$55.4M Buy
2,439,750
+1,208,222
+98% +$56.3M 0.12% 123
2019
Q1
$58.7M Buy
1,231,528
+221,392
+22% +$11M 0.09% 126
2018
Q4
$52.5M Sell
1,010,136
-91,480
-8% -$4.92M 0.09% 115
2018
Q3
$68.4M Buy
1,101,616
+38,637
+4% +$2.29M 0.13% 109
2018
Q2
$58.8M Buy
1,062,979
+170,360
+19% +$9.2M 0.12% 119
2018
Q1
$56.4M Buy
892,619
+174,170
+24% +$11.2M 0.13% 94
2017
Q4
$44M Buy
718,449
+82,980
+13% +$5.19M 0.13% 105
2017
Q3
$40.5M Buy
635,469
+63,857
+11% +$3.73M 0.13% 96
2017
Q2
$31.8M Buy
571,612
+107,021
+23% +$5.82M 0.1% 121
2017
Q1
$25.3M Buy
464,591
+162,884
+54% +$8.93M 0.07% 144
2016
Q4
$17.6M Buy
301,707
+238,895
+380% +$13.1M 0.05% 144
2016
Q3
$3.39M Buy
62,812
+39,639
+171% +$2.55M 0.01% 243
2016
Q2
$1.71M Sell
23,173
-3,775
-14% -$267K 0.01% 254
2016
Q1
$1.72M Sell
26,948
-38,161
-59% -$2.41M 0.01% 212
2015
Q4
$4.48M Sell
65,109
-2,455
-4% -$162K 0.03% 160
2015
Q3
$4M Buy
67,564
+5,601
+9% +$355K 0.02% 168
2015
Q2
$4.12M Sell
61,963
-323
-0.5% -$21.3K 0.02% 198
2015
Q1
$4.02M Sell
62,286
-21,775
-26% -$1.36M 0.02% 199
2014
Q4
$4.96M Buy
84,061
+36,745
+78% +$2.07M 0.02% 187
2014
Q3
$2.6M Buy
47,316
+30
+0.1% +$1.5K 0.01% 243
2014
Q2
$2.29M Buy
47,286
+4,468
+10% +$220K 0.01% 266
2014
Q1
$2.26M Sell
42,818
-31
-0.1% -$1.65K 0.01% 250
2013
Q4
$2.28M Buy
42,849
+26,029
+155% +$1.33M 0.01% 236
2013
Q3
$777K Buy
16,820
+5,100
+44% +$224K ﹤0.01% 335
2013
Q2
$525K Buy
+11,720
New +$509K ﹤0.01% 387

Other funds holding BMY

Toronto Dominion Bank's BMY Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, selling an estimated $25.1M and leaving 909,773 shares worth $55.2M. The position accounts for 0.08% of the portfolio, ranked #222.

Toronto Dominion Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $146M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Toronto Dominion Bank held 909,773 shares of Bristol-Myers Squibb worth $55.2M as of Q1 2026.
  • Toronto Dominion Bank sold 430,738 Bristol-Myers Squibb shares in Q1 2026, an estimated $25.1M.
  • Bristol-Myers Squibb made up 0.08% of Toronto Dominion Bank's portfolio in Q1 2026, its #222 holding.
  • Toronto Dominion Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Bristol-Myers Squibb position peaked at $146M in Q4 2019.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.